PhageTech Inc.
Handheld biosensor offers instant test results for bladder cancer
This article was originally published in Start Up
Executive Summary
A handheld biosensor in development by PhageTech Inc. is designed to detect the presence of several biomarkers associated with the recurrence of bladder cancer from a small urine sample, without the need for expensive and time-consuming lab-based tests. The device could also monitor treatment.